T50.A12A Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter

Summary

This condition describes intentional self-harm resulting from exposure to a pertussis (whooping cough) vaccine, either alone or in combination with other vaccine components, during the initial medical encounter following the event. Clinical presentation and management depend on the nature of the exposure and the patient's response.

Causes

Intentional self-harm may occur due to deliberate administration of an incorrect dose, improper handling of the vaccine, or exposure through intentional ingestion or injection of vaccine materials. The pertussis vaccine component, such as the inactivated or acellular antigen, is the primary agent involved in the toxic or adverse reaction.

Risk Factors

• History of suicidal ideation or prior self-harm attempts
• Access to vaccine materials (e.g., healthcare workers, individuals with vaccine storage)
• Mental health conditions affecting judgment or impulse control
• Knowledge of vaccine administration or handling

Symptoms

• Local reactions: swelling, redness, or pain at the injection site
• Systemic reactions: fever, irritability, or mild allergic responses (e.g., rashes)
• Severe reactions: high fever, breathing difficulties, seizures, or anaphylaxis
• Behavioral signs of intentional self-harm (e.g., inconsistent history, self-inflicted injuries)

Diagnosis

Diagnosis is based on a history of intentional vaccine exposure, clinical evaluation of symptoms, and exclusion of other causes. Laboratory tests or allergist consultation may be used to assess allergic or toxic responses. Documentation of intent and initial encounter timing is critical.

Treatment Options

Management focuses on stabilizing the patient, addressing symptoms, and providing psychological support. This may include antihistamines for allergic reactions, antipyretics for fever, and monitoring for severe complications. Referral to mental health services is often necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most mild reactions resolve with supportive care, while severe reactions may require extended monitoring. Follow-up includes assessing for ongoing symptoms and addressing underlying mental health concerns.

Complications

• Severe allergic reactions (e.g., anaphylaxis)
• Neurological effects (e.g., seizures, encephalopathy)
• Organ damage from toxic exposure
• Psychological sequelae related to self-harm

Lifestyle & Prevention

• Secure storage of vaccines to limit access
• Education on safe vaccine handling and disposal
• Mental health support for at-risk individuals
• Training for healthcare providers to recognize and respond to self-harm

When to Seek Professional Help

Seek immediate medical attention if symptoms like difficulty breathing, severe swelling, or altered mental status occur. Psychological evaluation is recommended for intentional self-harm to address underlying risks.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Ensure the pertussis vaccine component is specified, and note any combination with other vaccine components. Use this code only for initial encounters related to intentional self-harm.